ArticleBlood cancer journal2016

MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma.

P de la Puente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.